Related references
Note: Only part of the references are listed.Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received
David E. Neal et al.
EUROPEAN UROLOGY (2020)
Hyprofractionated Versus Conventionally Fractionated Radiation Therapy for Patients with Intermediate- or High-Risk, Localized, Prostate Cancer: 7-Year Outcomes From the Randomized, Multicenter, Open-Label, Phase 3 HYPRO Trial
Kim C. de Vries et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Patient-reported Outcomes Following Treatment of Localised Prostate Cancer and Their Association with Regret About Treatment Choices
Marie-Anne van Stam et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
PhaseII study of accelerated Linac-based SBRT in five consecutive fractions for localized prostate cancer
Filippo Alongi et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Moderate versus extreme hypofractionated radiotherapy: a toxicity comparative analysis in low- and favorable intermediate-risk prostate cancer patients
Luca Nicosia et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2019)
MR-guidance in clinical reality: current treatment challenges and future perspectives
S. Corradini et al.
RADIATION ONCOLOGY (2019)
A Prospective Single-Arm Phase 2 Study of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Prostate Cancer: Early Toxicity Results
Anna M. E. Bruynzeel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial
Douglas H. Brand et al.
LANCET ONCOLOGY (2019)
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study
Francesco Cuccia et al.
TUMORI JOURNAL (2019)
Adaptive radiotherapy: The Elekta Unity MR-linac concept
Dennis Winkel et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2019)
Erectile function after stereotactic body radiotherapy for localized prostate cancer
Robert T. Dess et al.
BJU INTERNATIONAL (2018)
Moderate Hypofractionated Postprostatectomy Volumetric Modulated Arc Therapy With Daily Image Guidance (VMAT-IGRT): A Mono-institutional Report on Feasibility and Acute Toxicity
Sergio Fersino et al.
CLINICAL GENITOURINARY CANCER (2017)
Extreme hypofractionation for early prostate cancer: Biology meets technology
Berardino De Bari et al.
CANCER TREATMENT REVIEWS (2016)
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
David Dearnaley et al.
LANCET ONCOLOGY (2016)
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer
J. L. Donovan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F. C. Hamdy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer
Ruggero Ruggieri et al.
BRITISH JOURNAL OF RADIOLOGY (2015)
Development and Validation of an Abbreviated Version of the Expanded Prostate Cancer Index Composite Instrument for Measuring Health-related Quality of Life Among Prostate Cancer Survivors
Konrad M. Szymanski et al.
UROLOGY (2010)
An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer
George van Andel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Claustrophobia during magnetic resonance imaging: Cohort study in over 55,000 patients
Marc Dewey et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2007)
Share Paper
